Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Joseph Bertino, Pharm.D.

Joseph Bertino, Pharm.D., Independent Consultant, Bertino ConsultingIndependent Consultant
Bertino Consulting
Member of the Healthcare Council

Joseph Bertino, PharmD, is an Associate Professor of Pharmacology at Columbia University College of Physicians and Surgeons in New York. Through Bertino Consulting, he consults to the pharmaceutical industry in areas of infectious diseases, drug metabolism, and clinical pharmacology. Dr. Bertino's research interests are in vaccines, antimicrobial pharmacokinetics and pharmacodynamics, pharmacogenetics, and pharmacogenomics. His publications include work in the area of aminoglycoside pharmacokinetics, pharmacodynamics and toxicity, drug-drug interactions, vaccine pharmacology, and application of pharmacogenetics to the drug development process. Dr. Bertino has also served on the Food and Drug Administration's Anti-infective and Antiviral Advisory Committees and remains as a special government employee. He is a recipient of the American College of Clinical Pharmacology Distinguished Investigator Award and the American College of Clinical Pharmacy Clinical Practice award. (This is me - Update Profile)


Employment History
2007 - present Independent Consultant
Bertino Consulting
2005 - present Associate Professor of Pharmacology
Columbia University College of Physicians and Surgeons
2005 - 2007 Scientific Director in Drug Development Center
Ordway Research Institute Inc
1997 - 2005 Associate Professor of Clinical Pharmacology
Columbia University
1982 - 2005 Section Chief of Clinical Pharmacology
THE MARY IMOGENE BASSETT HOSPITAL, INC.

GLG Study Groups with Joseph Bertino, Pharm.D.(?)

GLG NewsSM Analyses by Joseph Bertino, Pharm.D.(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Astra-Zeneca and Abbott partner on promoting Crestor..should Pfizer beware? | 08-15-2008
Analysis of: Abbott signs deal to promote Crestor in U.S. | www.chicagotribune.com
Author: Joseph Bertino, Pharm.D., Independent Consultant, Bertino Consulting

-Crestor sold 2.8 billion dollars in sales in the recent year, will this partnership result in long term exponential growth? -What are the implications for Crestor with generic simvastatin and with Lipitor going generic in the next few years? -Is a combination product going to bolster Crestor sales

The New PhRMA “Code on Interactions with Health Care Professionals”: What will it mean? | 07-17-2008
Author: Joseph Bertino, Pharm.D., Independent Consultant, Bertino Consulting

-The new code will limit all gifts and meals to healthcare professionals, thus reducing pharmaceutical representative contact time. -Medical education programs will follow guidelines established by professional education groups -The guidelines do not go far enough for sales representative-healthcare...

Non-Inferiority Studies: What do the numbers mean, how does the FDA interpret them? | 10-11-2007
Author: Joseph Bertino, Pharm.D., Independent Consultant, Bertino Consulting

A recent abstract for the 2007 Infectious Diseases Society of American (IDSA) meeting has generated some concern among financial analysts.  This non-inferiority study on iclaprim versus linezolid for treatment of complicated skin and skin structure infections showed that “The 95% CI for treatment...

GLG InstituteSM Seminars with Joseph Bertino, Pharm.D.(?)

 
Joseph Bertino, Pharm.D. has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare

Request a project with Joseph Bertino, Pharm.D.









Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-09-04T21:45:16.757